Following the emergence of the SARS-CoV-2 (Covid-19) pandemic, interest in understanding antibody diagnostic testing has increased. We describe a quick and inexpensive technique that enabled students to print their own microfluidic devices that can be used to house an immunoassay for detecting a Human Immunodeficiency Virus (HIV) antibody. Both qualitative diagnostic assays and quantitative binding assays were carried out to characterize the HIV interaction with a target antibody. By performing these hands-on low-cost experiments in the analytical chemistry lab course, students were exposed to 3D fabrication, microfluidic technology, surface chemistry, protein-ligand binding affinity studies, and immunoassays within the time frame of two four–hour laboratory periods.
No takes yet. Share an insight, caveat, or question.
Greenberger et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: